Hybrid consensus and k-nearest neighbours (kNN) strategies to classify dual BRD4/PLK1 inhibitors

References

• T. Stankovic, J. Dinić, A. Podolski-Renic, L. Musso, S. Buric, S. Dallavalle, and M. Pesic, Dual inhibitors as a new challenge for cancer multidrug resistance treatment, Curr. Med. Chem. 26 (2019), pp. 6074–6106. doi:10.2174/0929867325666180607094856.
   PubMed Web of Science ®Google Scholar
• J. Liu, S. Teng, L. Fei, W. Zhang, X. Fang, Z. Zhang, and N. Wu, A novel consensus learning approach to incomplete multi-view clustering, Pattern Recogn. 115 (2021), pp. 107890. doi:10.1016/j.patcog.2021.107890.
   Web of Science ®Google Scholar
• R. Qaddoura, H. Faris, and I. Aljarah, An efficient clustering algorithm based on the k-nearest neighbors with an indexing ratio, Int. J. Mach. Learn. 11 (2020), pp. 675–714. doi:10.1007/s13042-019-01027-z.
   Web of Science ®Google Scholar
• Z. Wu, B. Jin, H. Fujita, and J. Xu, Consensus analysis for AHP multiplicative preference relations based on consistency control: A heuristic approach, Knowl. Based Syst. 191 (2020), pp. 105317. doi:10.1016/j.knosys.2019.105317.
   Web of Science ®Google Scholar
• L. Aguilera-Mendoza, Y. Marrero-Ponce, C.R. García-Jacas, E. Chavez, J.A. Beltran, H.A. Guillen-Ramirez, and C.A. Brizuela, Automatic construction of molecular similarity networks for visual graph mining in chemical space of bioactive peptides: An unsupervised learning approach, Sci. Rep. 10 (2020), pp. 1–23. doi:10.1038/s41598-020-75029-1.
   PubMed Web of Science ®Google Scholar
• A. Yoshimori, H. Hu, and J. Bajorath, Adapting the DeepSARM approach for dual-target ligand design, J. Comput. Aided Mol. 35 (2021), pp. 587–600. doi:10.1007/s10822-021-00379-5.
   PubMed Web of Science ®Google Scholar
• P. Tang, J. Zhang, J. Liu, C.M. Chiang, and L. Ouyang, Targeting bromodomain and extraterminal proteins for drug discovery: From current progress to technological development, J. Med. Chem. 64 (2021), pp. 2419–2435. doi:10.1021/acs.jmedchem.0c01487.
   PubMed Web of Science ®Google Scholar
• N.Y. Wang, Y. Xu, K.J. Xiao, W.Q. Zuo, Y.X. Zhu, R. Hu, W.L. Wang, Y.J. Shi, L.T. Yu, and Z.H. Liu, Design, synthesis, and biological evaluation of 4, 5-dihydro-[1, 2, 4]triazolo [4, 3-f] pteridine derivatives as novel dual-PLK1/BRD4 inhibitors, Eur. J. Med. Chem. 191 (2020), pp. 112152. doi:10.1016/j.ejmech.2020.112152.
   PubMed Web of Science ®Google Scholar
• S. Liu, H.O. Yosief, L. Dai, H. Huang, G. Dhawan, X. Zhang, A.M. Muthengi, J. Roberts, D.L. Buckley, J.A. Perry, L. Wu, J.E. Bradner, J. Qi, and W. Zhang, Structure-guided design and development of potent and selective dual bromodomain 4 (BRD4)/polo-like kinase 1 (PLK1) inhibitors, J. Med. Chem. 61 (2018), pp. 7785–7795. doi:10.1021/acs.jmedchem.8b00765.
   PubMed Web of Science ®Google Scholar
• E. Watts, D. Heidenreich, E. Tucker, M. Raab, K. Strebhardt, L. Chesler, S. Knapp, B. Bellenie, and S. Hoelder, Designing dual inhibitors of anaplastic lymphoma kinase (ALK) and bromodomain-4 (BRD4) by tuning kinase selectivity, J. Med. Chem. 62 (2019), pp. 2618–2637. doi:10.1021/acs.jmedchem.8b01947.
   PubMed Web of Science ®Google Scholar
• J.B. Tong, D. Luo, Y. Feng, S. Bian, X. Zhang, and T.H. Wang, Structural modification of 4, 5-dihydro-[1, 2, 4] triazolo [4, 3-f] pteridine derivatives as BRD4 inhibitors using 2D/3D-QSAR and molecular docking analysis, Mol. Divers. 25 (2021), pp. 1855–1872. doi:10.1007/s11030-020-10172-5.
   PubMed Web of Science ®Google Scholar
• D. Luo, J.B. Tong, X.C. Xiao, S. Bian, X. Zhang, J. Wang, and H.Y. Xu, Theoretically exploring selective-binding mechanisms of BRD4 through integrative computational approaches, SAR. QSAR Environ. Res. 32 (2021), pp. 985–1011. doi:10.1080/1062936X.2021.1999317.
   PubMed Web of Science ®Google Scholar
• J.B. Tong, D. Luo, S. Bian, and X. Zhang, Structural investigation of tetrahydropteridin analogues as selective PLK1 inhibitors for treating cancer through combined QSAR techniques, molecular docking, and molecular dynamics simulations, J. Mol. Liq. 335 (2021), pp. 116235. doi:10.1016/j.molliq.2021.116235.
   Web of Science ®Google Scholar
• Y. Kong and A. Yan, QSAR models for predicting the bioactivity of Polo-Like Kinase 1 inhibitors, Chemom. Intell. Lab. Syst. 167 (2017), pp. 214–225. doi:10.1016/j.chemolab.2017.06.011.
   Web of Science ®Google Scholar
• X. Mu, L. Bai, Y. Xu, J. Wang, and H. Lu, Protein targeting chimeric molecules specific for dual bromodomain 4 (BRD4) and polo-like kinase 1 (PLK1) proteins in acute myeloid leukemia cells, Biochem. Biophys. Res. 521 (2020), pp. 833–839. doi:10.1016/j.bbrc.2019.11.007.
   PubMed Web of Science ®Google Scholar
• M. Asadollahi-Baboli and S. Dehnavi, Docking and QSAR analysis of tetracyclic oxindole derivatives as α-glucosidase inhibitors, Comput. Biol. Chem. 76 (2018), pp. 283–292. doi:10.1016/j.compbiolchem.2018.07.019.
   PubMed Web of Science ®Google Scholar
• M. Asadollahi-Baboli, In silico evaluation, molecular docking and QSAR analysis of quinazoline-based EGFR-T790M inhibitors, Mol. Divers. 20 (2016), pp. 729–739. doi:10.1007/s11030-016-9672-0.
   PubMed Web of Science ®Google Scholar
• F. Grisoni, V. Consonni, and R. Todeschini, Impact of molecular descriptors on computational models, in Computational Chemogenomics, J.B. Brown (ed.), Humana Press, New York, NY, pp. 171–209, 2018.
   Google Scholar
• I. Triguero, D. García‐Gil, J. Maillo, J. Luengo, S. García, and F. Herrera, Transforming big data into smart data: An insight on the use of the k‐nearest neighbors algorithm to obtain quality data, Data Min. Knowl. Discov. 9 (2019), pp. 1289.
   Web of Science ®Google Scholar
• D. Ballabio and V. Consonni, Classification tools in chemistry. Part 1: Linear models. PLS-DA, Anal. Meth. 5 (2013), pp. 3790–3798. doi:10.1039/c3ay40582f.
   Web of Science ®Google Scholar
• T.B. Chandra, K. Verma, B.K. Singh, D. Jain, and S.S. Netam, Coronavirus disease (COVID-19) detection in Chest X-Ray images using majority voting based classifier ensemble, Expert Syst. Appl. 165 (2021), pp. 113909. doi:10.1016/j.eswa.2020.113909.
   PubMed Web of Science ®Google Scholar
• F. Grisoni, V. Consonni, and D. Ballabio, Machine learning consensus to predict the binding to the androgen receptor within the CoMPARA project, J. Chem. Inf. Model. 59 (2019), pp. 1839–1848. doi:10.1021/acs.jcim.8b00794.
   PubMed Web of Science ®Google Scholar
• D. Ballabio, F. Grisoni, V. Consonni, and R. Todeschini, Integrated QSAR models to predict acute oral systemic toxicity, Mol. Inform. 38 (2019), pp. 1800124. doi:10.1002/minf.201800124.
   Web of Science ®Google Scholar
• C. Valsecchi, F. Grisoni, V. Consonni, and D. Ballabio, Consensus versus individual QSARs in classification: Comparison on a large-scale case study, J. Chem. Inf. Model. 60 (2020), pp. 1215–1223. doi:10.1021/acs.jcim.9b01057.
   PubMed Web of Science ®Google Scholar
• M. Gholamhoseinnia and M. Asadollahi-Baboli, Ranked binding energies of residues and data fusion to identify the active and selective pyrimidine-based Janus kinases 3 (JAK3) inhibitors, SAR QSAR Environ. Res. 33 (2022), pp. 23–34. doi:10.1080/1062936X.2021.2013318.
   PubMed Web of Science ®Google Scholar
• M. Asadollahi-Baboli and A. Mani-Varnosfaderani, Therapeutic index modeling and predictive QSAR of novel thiazolidin-4-one analogs against Toxoplasma gondii, Eur. J. Pharm. 70 (2015), pp. 117–124. doi:10.1016/j.ejps.2015.01.014.
   Google Scholar
• J. Li, M. Gao, and R. D’Agostino, Evaluating classification accuracy for modern learning approaches, Stat. Med. 38 (2019), pp. 2477–2503. doi:10.1002/sim.8103.
   PubMed Web of Science ®Google Scholar
• K. Seraj and M. Asadollahi-Baboli, In silico evaluation of 5-hydroxypyrazoles as LSD1 inhibitors based on molecular docking derived descriptors, J. Mol. Struct. 1179 (2019), pp. 514–524. doi:10.1016/j.molstruc.2018.11.019.
   Web of Science ®Google Scholar
• J. Novak, M.A. Grishina, V.A. Potemkin, and J. Gasteiger, Performance of radial distribution function-based descriptors in the chemoinformatic studies of HIV-1 protease, Future Med. Chem. 12 (2020), pp. 299–309. doi:10.4155/fmc-2019-0241.
   PubMed Web of Science ®Google Scholar
• Z. Kalaki and M. Asadollahi-Baboli, Molecular docking-based classification and systematic QSAR analysis of indoles as Pim kinase inhibitors, SAR QSAR Environ. Res. 31 (2020), pp. 399–419. doi:10.1080/1062936X.2020.1751277.
   PubMed Web of Science ®Google Scholar